Vizz: A Breakthrough in Vision Care and What It Means for Minority Communities
A New Era in Treating Presbyopia In 2025, the U.S. Food and Drug Administration approved Vizz (aceclidine ophthalmic solution 1.44%), a revolutionary once-daily eye drop designed to address presbyopia—age-related near […]
Vizz: A Breakthrough in Vision Care and What It Means for Minority Communities Read More »
